Health Industry
661 - 680 of 3,934 Results
-
-
As AI Eye Exams Prove Their Worth, Lessons for Future Tech Emerge
With artificial intelligence in health care on the rise, eye screenings for diabetic retinopathy are emerging as one of the first proven use cases of AI-based diagnostics in a clinical setting.
-
Navigating Aging
The Burden of Getting Medical Care Can Exhaust Older Patients
It’s estimated that an older patient can spend three weeks of the year getting care — and that doesn’t count the time it takes to arrange appointments or deal with insurance companies.
-
Some Medicaid Providers Borrow or Go Into Debt Amid ‘Unwinding’ Payment Disruptions
Used to operating with scarce resources, Montana Medicaid providers say gaps in state payments have left them struggling further.
-
-
Overdosing on Chemo: A Common Gene Test Could Save Hundreds of Lives Each Year
The FDA and some oncologists have resisted efforts to require a quick, cheap gene test that could prevent thousands of deaths from a bad reaction to a common cancer drug.
By Arthur Allen -
After Appalachian Hospitals Merged Into a Monopoly, Their ERs Slowed to a Crawl
Ballad Health was granted the nation’s largest state-sanctioned hospital monopoly in 2018. Since then, its emergency rooms have become more than three times as slow.
By Brett Kelman and Samantha Liss The ACA Turns 14
Episode 339Saturday marks the 14th anniversary of the still somewhat embattled Affordable Care Act. Health and Human Services Secretary Xavier Becerra joins host Julie Rovner to discuss the accomplishments of the health law — and the challenges it still faces. Also this week, Alice Miranda Ollstein of Politico, Tami Luhby of CNN, and Mary Agnes Carey of ýҕl Health News join Rovner to discuss what should be the final funding bill for HHS for fiscal 2024, next week’s Supreme Court oral arguments in a case challenging abortion medication, and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week they think you should read, too.
-
Social Security Chief Testifies in Senate About Plans to Stop ‘Clawback Cruelty’
Commissioner Martin O’Malley testifies to two Senate panels that his agency will stop the “injustices” of suspending people’s monthly benefits to recover alleged overpayments. The burden will be on the Social Security Administration to prove the beneficiary was to blame.
-
ýҕl Health News & PolitiFact HealthCheck
Biden Said Medicare Drug Price Negotiations Cut the Deficit by $160B. That’s Years Away.
Savings estimated by the Congressional Budget Office from allowing the federal government to negotiate Medicare drug prices are based on a 10-year cumulative projection.
-
Needle Pain Is a Big Problem for Kids. One California Doctor Has a Plan.
The pain and trauma from repeated needle sticks leads some kids to hold on to needle phobia into adulthood. Research shows the biggest source of pain for children in the health care system is needles. But one doctor thinks he has a solution and is putting it into practice at two children’s hospitals in Northern California.
-
Georgia’s Medicaid Work Requirements Costing Taxpayers Millions Despite Low Enrollment
Republican Gov. Brian Kemp’s Georgia Pathways to Coverage program has seen anemic enrollment while chalking up millions in start-up costs — largely in technology and consulting fees. Critics say the money’s being wasted on a costly and ineffective alternative to Obamacare’s Medicaid expansion.
By Andy Miller and Renuka Rayasam -
-
When Copay Assistance Backfires on Patients
Drugmakers offer copay assistance programs to patients, but insurers are tapping into those funds, not counting the amounts toward patient deductibles. That leads to unexpected charges. But the practice is under growing scrutiny.
-
Perspective
How Your In-Network Health Coverage Can Vanish Before You Know It
One of the most unfair aspects of medical insurance is this: Patients can change insurance only during end-of-year enrollment periods or at the time of “qualifying life events.” But insurers’ contracts with doctors, hospitals, and pharmaceutical companies can change abruptly at any time.
Maybe It’s a Health Care Election After All
Episode 338Health care wasn’t expected to be a major theme for this year’s elections. But as President Joe Biden and former President Donald Trump secured their respective party nominations this week, the future of both Medicare and the Affordable Care Act appears to be up for debate. Meanwhile, the cyberattack of the UnitedHealth Group subsidiary Change Healthcare continues to do damage to the companies’ finances with no quick end in sight. Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News, and Joanne Kenen of Johns Hopkins University and Politico Magazine join ýҕl Health News’ Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Kelly Henning of Bloomberg Philanthropies about a new, four-part documentary series on the history of public health, “The Invisible Shield.” Plus, for “extra credit” the panelists suggest health policy stories they read this week that they think you should read, too.
-
Exclusive: Social Security Chief Vows to Fix ‘Cruel-Hearted’ Overpayment Clawbacks
New Social Security Commissioner Martin O’Malley is promising to change how the agency reclaims billions of dollars it wrongly pays to beneficiaries, saying the existing process is “cruel-hearted and mindless.”
-
Concerns Grow Over Quality of Care as Investor Groups Buy Not-for-Profit Nursing Homes
For-profit groups own more than 70% of U.S. nursing homes. Industry leaders and researchers wonder whether corporations and investors can succeed where not-for-profit organizations have struggled. Or, will quality of care suffer in the name of making money?
By Harris Meyer -
A New $16,000 Postpartum Depression Drug Is Here. How Will Insurers Handle It?
A pill form of an effective drug for postpartum depression hit the market in December, but most insurers do not yet have a policy on when or whether they will pay for it. The hurdles to obtain its predecessor medication have advocates worried.
-
How the Anti-Vaccine Movement Pits Parental Rights Against Public Health
Framed in the rhetoric of choice, Tennessee’s new law governing childhood vaccinations is among more than a dozen recently passed or pending nationwide that set parental freedom against community and children’s health.
By Amy Maxmen